Log In
BCIQ
Print this Print this
 

BBT-401

  Manage Alerts
Collapse Summary General Information
Company Bridge Biotherapeutics Inc.
DescriptionN-terminal lipidated 4aa peptide targeting pellino E3 ubiquitin protein ligase 1 (PELI1; pellino-1)
Molecular Target Pellino E3 ubiquitin protein ligase 1 (PELI1) (pellino-1)
Mechanism of Action 
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today